SCHEMBL22639006

SCHEMBL22639006

O=C1CNCCN1C(=O)N1CCNCC1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.35
CHKA P35790 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA9 Q16790 1/20 0.32
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
CHRNB2 P17787 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30
CHRNB3 Q05901 1/20 0.30
CHRNA6 Q15825 1/20 0.30
FAAH O00519 1/20 0.30
NAAA Q02083 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2360226 0.84 SIGMAR1 (0.33) CA2CHKANPSR1CA12CA1
SCHEMBL8264195 0.83 NPSR1 (0.33) CA2NPSR1CA12CA1CA9
SCHEMBL2697578 0.83 HTR2A (0.30) CA2NPSR1CA12CA1CA9
SCHEMBL7407795 0.82 MEN1 (0.43) NPSR1CA12CA1CA9POLB
SCHEMBL13590825 0.79 LMNA (0.37) FAAHNAAA
SCHEMBL28637773 0.78 CA12 (0.31) CA2CA12CA1CA9
SCHEMBL7614938 0.78 CASP2 (0.36) SLC6A2SLC6A4SLC6A3ALDH1A1POLB
SCHEMBL29381349 0.77 FAAH (0.39) ALDH1A1FAAH
SCHEMBL20038268 0.77
SCHEMBL7048298 0.75 HRH3 (0.36) ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021239058-A1 FUSED TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 劲方医药科技(上海)有限公司 2021-12-02 WO disclosed
WO-2020224656-A1 BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 劲方医药科技(上海)有限公司 2020-11-12 WO disclosed